Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Blood Pressure Management in High-Risk Patients

Introduction to Blood Pressure Targets

  • The American College of Cardiology recommends a blood pressure target of <130/80 mmHg for patients with diabetes and hypertension, representing a balance between cardiovascular benefit and risk of adverse events 2, 3

Key Findings on Intensive Treatment

  • Intensive blood pressure treatment targeting systolic blood pressure <120 mmHg significantly reduces cardiovascular events by 25% compared to standard treatment targeting <140 mmHg, though with increased risk of adverse events 1, 2
  • The SPRINT trial, which enrolled 9,361 patients with systolic blood pressure ≥130 mmHg and increased cardiovascular risk, demonstrated a 25% reduction in the composite outcome of myocardial infarction, coronary syndromes, stroke, heart failure, or cardiovascular death in the intensive treatment group 1

Comparison with Other Trials

  • The ACCORD BP trial specifically studied patients with type 2 diabetes and demonstrated a significant 41% reduction in stroke in the intensive treatment group, although it did not show a statistically significant reduction in the primary composite cardiovascular endpoint 1, 2

Adverse Events Associated with Intensive Treatment

  • The intensive treatment arm experienced more adverse events, including hypotension, syncope, electrolyte abnormalities, acute kidney injury, bradycardia, hyperkalemia, and elevations in serum creatinine 1, 2, 3

Clinical Implications and Guidelines

  • Current guidelines recommend individualized blood pressure targets through shared decision-making that considers cardiovascular risk, potential adverse effects, and patient preferences 2
  • The American College of Cardiology suggests that treatment should not aim for blood pressure <120/80 mmHg as a mean achieved blood pressure below this threshold is associated with increased adverse events 2

Special Populations and Considerations

  • For pregnant individuals with diabetes and chronic hypertension, a blood pressure threshold of 140/90 mmHg for initiating or titrating therapy is associated with better pregnancy outcomes, and a target of 110-135/85 mmHg is suggested to reduce the risk of accelerated maternal hypertension 2, 3